Latest article
Juntendo College analysis: Aromatherapy in medication: Important oils show to be efficient in opposition...
TOKYO, August 24, 2021 / PRNewswire...
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Youngsters’ well being and health in 2021
This week's column is focused on children's health and fitness. In 2020 I noticed a lot of kids dealing with changes like less...